Full-Time

Facilities Manager

MedPharm

MedPharm

Topical and transdermal drug delivery CDMO

No salary listed

Guildford, UK

In Person

Site-based role at the Guildford facility; occasional travel, out-of-hours, or weekend work may be required.

Bachelor's

Category
Facilities Operations (2)
,
Required Skills
Microsoft Office
Forecasting
Requirements
  • At least 5 years of pharmaceutical or relevant industry experience.
  • A science or engineering-related degree is preferred.
  • Experience delivering training.
  • Experience providing informal team supervision.
  • Strong understanding of facilities management within regulated laboratory environments.
  • Working knowledge of GxP, quality systems, and data integrity principles.
  • Sound knowledge of UK health and safety legislation and best practices.
  • Strong contractor and vendor management experience.
  • Ability to manage multiple priorities and respond effectively to operational demands.
  • Proficient in Microsoft Office applications.
  • Ability to work on a site-based role covering office and laboratory environments.
  • Ability to perform site walkdowns, inspections, and extended walking in internal and external operational areas.
  • Ability to inspect equipment and infrastructure, including occasional work at height and in confined spaces.
  • Ability to lift or move equipment within safe limits and use appropriate personal protective equipment.
  • Sufficient hearing ability to communicate with staff and contractors and detect alarms or equipment sounds.
  • Ability to respond to facility emergencies requiring extended standing, walking, or physical activity.
Responsibilities
  • Oversee the day-to-day operation of facilities, ensuring buildings, infrastructure, and critical systems are maintained in a compliant and operational state.
  • Lead and support facility upgrades, modifications, and capital projects, ensuring delivery to scope, budget, and regulatory requirements.
  • Manage external contractors and service providers, ensuring work is appropriately scoped, scheduled, and delivered in line with health and safety and GxP requirements.
  • Maintain oversight of facilities-related equipment and asset lifecycle management, including servicing, calibration, and preventative maintenance programmes.
  • Ensure site utilities, including electricity, gas, water, air conditioning, and waste systems, are maintained and compliant with relevant legislation and best practice.
  • Act as the primary point of contact for facilities-related issues and ensure timely resolution and clear communication to stakeholders.
  • Ensure appropriate disaster recovery and business continuity plans are in place for facilities operations.
  • Maintain accurate and audit-ready facilities documentation, records, and contracts.
  • Ensure facilities operations comply with GxP standards, UK HSE legislation, COSHH, and internal quality systems.
  • Maintain inspection readiness and support Quality Assurance with internal audits, external inspections, and associated quality records.
  • Oversee facilities-related standard operating procedures, ensuring they are current, effective, and aligned with regulatory expectations.
  • Ensure facilities activities are documented, controlled, and aligned with data integrity principles.
  • Escalate risks to compliance, operations, accreditation, or insurance status to senior management.
  • Lead the development, implementation, and continuous improvement of site-wide health and safety systems across office and laboratory environments.
  • Oversee risk assessment and COSHH processes, ensuring timely completion, review, and implementation of control measures.
  • Lead incident reporting and investigations, including root cause analysis and CAPA implementation.
  • Conduct regular health and safety inspections and audits, ensuring actions are tracked and closed within agreed timelines.
  • Oversee health and safety training programmes, deliver site inductions and awareness programmes, and promote a proactive safety culture.
  • Ensure compliance with health and safety inspections and specialist risk assessments.
  • Drive continuous improvement initiatives to enhance safety, compliance, operational efficiency, and cost control.
  • Support management of the UK service and maintenance budget and UK capital expenditure budgets.
  • Monitor spend, track forecasts, and identify cost-saving opportunities without compromising compliance or safety.
  • Manage supplier performance, contracts, and service level agreements to ensure quality and value.
  • Provide technical guidance and support to internal teams involved in facilities and health and safety activities.
  • Work cross-functionally with Quality Assurance, laboratory teams, finance, and senior leadership to align facilities operations with business needs.
  • Act as a key contact for external contractors, auditors, and regulatory bodies.
  • Promote a culture of accountability, safety, and continuous improvement across the site.
  • Occasionally travel to support role-specific tasks or attend external training sessions.
  • Perform occasional out-of-hours or weekend work to support maintenance activities or respond to incidents.
Desired Qualifications
  • IOSH or NEBOSH qualification preferred.

MedPharm is a contract development and manufacturing organization specializing in topical, transdermal, and mucosal drug delivery. It provides end-to-end services from formulation development through clinical and commercial manufacturing, including analytical testing and regulatory support, and operates proprietary delivery platforms such as MedSpray, MedTherm, and AquaRMed. Its capabilities cover dermal, pulmonary, nasal, ophthalmic, and other mucosal routes, combining research services with a patent portfolio to support product lifecycle needs. In 2024 it merged with Tergus Pharma to expand into hormone-based and highly potent drugs, with the goal of helping pharmaceutical and biotech customers move from early formulation to scalable, reliable manufacturing for clinical and commercial use.

Company Size

N/A

Company Stage

Grant

Total Funding

$390K

Headquarters

Guildford, United Kingdom

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • February 2025 CEO Bill Humphries signals post-merger growth execution and commercial discipline.
  • The Durham $4 million expansion created space for over 100 skilled hires in RTP.
  • Palvella's positive March 2026 Phase 3 readout and Purna partnership strengthen sponsor validation.

What critics are saying

  • MedPharm depends on niche topical spending; a sponsor slowdown hits utilization fast in 2025-2026.
  • The 2024 merger left some Tergus leaders exiting, creating integration and execution risk.
  • Topical CDMO giants and captive pharma plants can compress margins and steal repeat programs.

What makes MedPharm unique

  • MedPharm remains the topical and transepithelial CDMO specialist after the 2024 Tergus merger.
  • Durham and Guildford sites give MedPharm integrated development, clinical manufacturing, and commercial production.
  • August 2026 Olink CSP status adds proprietary proteomics beyond formulation and in vitro testing.

Help us improve and share your feedback! Did you find this helpful?

Company News

FinSMEs
Jul 9th, 2024
MedPharm and Tergus Pharma Merge

MedPharm, a Guildford, UK-based topical and transdermal Contract Development and Manufacturing Organization (CDMO) and Ampersand Capital Partners portfolio company, announced a merger with Tergus Pharma, a Research Triangle Park, NC-based end-to-end contract service provider and a Great Point Partners portfolio company

FinSMEs
Jul 8th, 2024
MedPharm and Tergus Pharma Merge

MedPharm, a UK-based CDMO, has merged with Tergus Pharma, a US-based contract service provider. The combined entity will operate under the MedPharm name, offering end-to-end drug development and manufacturing services. Michael Kane, Tergus Pharma CEO, will become CEO of MedPharm, while Patrick Walsh remains Executive Chairman. Great Point Partners retains a significant minority stake, with Ampersand Capital Partners and Bourne Partners Strategic Capital holding majority ownership.